Author/Authors :
Azizi Fereidoun نويسنده , Eskandari Fatemeh نويسنده Prevention of metabolic diseases research center, Research Institute of endocrine sciences , Almasi-Hashiani Amir نويسنده Department of Epidemiology and Biostatistics, Faculty of Health, Arak University of Medical Sciences, Arak, Iran Almasi-Hashiani Amir , Cheraghi Zahra نويسنده Department of Epidemiology & Biostatistics, School of Public Heath, Hamedan University of Medical Sciences, Hamedan, Iran , Khalili Davood نويسنده Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Hadaegh Farzad نويسنده Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Ayubi Erfan نويسنده Department of Epidemiology and Biostatistics, School of Public Health and
Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran Ayubi Erfan , Fahimfar Noushin نويسنده Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran , Mansournia Mohammad Ali نويسنده School of Public Health,Department of Epidemiology and Biostatistics,Tehran University of Medical Sciences,Tehran,Iran , Holakouie-Naieni Kourosh نويسنده Department of Epidemiology and Biostatistics, School of
Public Health, Tehran University of Medical Sciences, Tehran,
Iran
Abstract :
Background High-risk individuals for CHD could be diagnosed by
some non-invasive and low-priced techniques such as Minnesota ECG coding
and rose angina questionnaire (RQ). Objectives The present study aimed
at determining the risk of incident CHD according to ECG and RQ besides
diabetes and other metabolic risk factors in our population. Methods
Participants comprised of 5431 individuals aged ≥ 30 years within the
framework of Tehran lipid and glucose study. Based on their status on
history of CHD, ECG, and RQ at baseline, all participants were
classified to 5 following groups: (1)
History-Rose-ECG-
(the reference group); (2)
History-Rose+ECG-;
(3)
History-Rose-ECG+;
(4)
History-Rose+ECG+;
and (5) History+. We used Cox regression model to
find the role of ECG and RQ on CHD, independent of other risk factors.
Results Overall, 562 CHD events were detected during the median of 10.3
years follow-up. CHD incidence rates were 55.9 and 9.09 cases per 1000
person-year for participants with and without history of CHD,
respectively. Hazard ratios (HRs) (95% CIs) were 4.11 (3.27 - 5.11) for
History + and 2.18 (1.63 - 2.90), 1.92 (1.47 - 2.51), and 2.48 (1.46 -
4.20) for
History-Rose+ECG-,
History-Rose-ECG+,
and
History-Rose+ECG+,
respectively. RQ and ECG had the same HRs as high as those for
hypertension and hypercholesterolemia; however, diabetes showed
statistically and clinically more effects on CVD than RQ and ECG.
Conclusions RQ in general and, ECG especially in asymptomatic patients,
were good predictors for CHD events in both Iranian males and females;
however, their predictive powers were lower than that of diabetes.